Aggressive Systemic and Multi-Modal Therapy to Treat Metastatic Kidney Cancer

Join oncologist Sandy Liu, MD, for a conversation about UCLA’s multi-disciplinary treatment approach to target advanced kidney cancer. The team approaches each case individually with the hope of eradicating all disease with aggressive systemic therapy and, when feasible, adding multi-modal therapy to consolidate residual disease.